Last reviewed · How we verify
NCT04922749: MULTI+
Evaluation of a Multidisciplinary Lifestyle Treatment for Inpatients With Mental Illness
NA trial testing MULTI+ in Mental Illness in 846 participants. Status unknown.
1 September 2022
Quick facts
| Lead sponsor | GGZ Centraal |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | sequential |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 846 |
| Start date | 1 July 2020 |
| Primary completion | 1 September 2022 |
| Estimated completion | 1 September 2022 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- MULTI+
Conditions studied
- Mental Illness — all drugs for Mental Illness →
- Lifestyle — all drugs for Lifestyle →
Sponsor
GGZ Centraal
Who can join
16 and older, any sex, with Mental Illness or Lifestyle. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
People with mental illness (MI) have a reduced life expectancy compared to the general population, mostly attributable to somatic diseases caused by poor physical health. Modifiable "lifestyle factors" have been increasingly associated with the onset of somatic diseases in people with MI and refer to health behaviours such as physical activity (PA), diet, sleep and smoking behaviour. Despite the evidence demonstrating the efficacy of interventions aimed at improving lifestyle factors, there have not been many structural changes in routine clinical care for people with MI. Using a multidisciplinary, multicomponent approach, Deenik and colleagues (2019) were the first to find long-term positive effects in both mental and somatic health in a real-world inpatient setting for people with severe mental illness (SMI). They found improvements in metabolic health, psychosocial functioning and quality of life, and a reduction in the use of psychotropic medication. The authors urged to confirm and complement findings in scaled-up studies, and made several suggestions for improvement of the treatment and pragmatic research of implementation. In line with these previous recommendations the MULTI is being scaled-up into the MULTI+. This study investigates the implementation and effectiveness of a multidisciplinary lifestyle treatment for inpatients with mental illness (MULTI+).
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Effectiveness and implementation of a multidisciplinary lifestyle focused approach in the treatment of inpatients with mental illness (MULTI +): a stepped wedge study protocol.
den Bleijker NM, van Schothorst MME, Hendriksen IJM, Cahn W, et al · · 2022 · cited 4× · PMID 35361168 · DOI 10.1186/s12888-022-03801-w -
Evaluating the Impact of a Lifestyle-Focused Approach on Cardiovascular Risk in Inpatients With Mental Illness: Analyzing Effectiveness and Fidelity in a Stepped Wedge Cluster Randomized Trial (MULTI+ Study V).
den Bleijker NM, van Schothorst MME, Reitsma JB, Hendriksen IJM, et al · · 2025 · PMID 40932842 · DOI 10.1176/appi.prcp.20240150 -
Barriers and facilitators of inpatients and healthcare professionals prior to the implementation of a Multidisciplinary Lifestyle-Focused Approach in the Treatment of Inpatients With Mental Illness (MULTI+): The MULTI+ Study II.
van Schothorst MME, den Bleijker NM, van Harten PN, De Vries NK, et al · · 2025 · PMID 40630921 · DOI 10.1177/26334895251351663 -
A network approach to lifestyle behaviors and health outcomes in people with mental illness: the MULTI+ study III.
den Bleijker NM, van Schothorst MME, Blanken TF, Hendriksen IJM, et al · · 2025 · PMID 40211776 · DOI 10.1192/j.eurpsy.2025.2442
Verify or expand the search:
- PubMed search for NCT04922749
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Mental Illness
Currently open trials in the same condition.
- NCT07396623 — Validation of French PHQ-4 and PC-PTSD-5 Screening Scales · recruiting
- NCT05776316 — Harm Reduction Services · NA · recruiting
- NCT04881084 — Exploring Empathy and Compassion Using Digital Narratives · NA · recruiting
- NCT06290648 — Forging New Paths: Building Interventions to Treat Criminogenic Needs in Community Based Mental Health Settings · NA · active not recruiting
- NCT06315114 — A Transdiagnostic Mentalization-based Intervention for Parents With Mental Disorders · NA · recruiting
Other GGZ Centraal trials
Trials by the same sponsor.
- NCT07464301 — Stress Autism Mate (SAM) App for Stress Management in Adults With Borderline Personality Disorder Traits · NA · completed
- NCT05600205 — Evaluation of Combined Support for the Ambulatory Lifestyle Intervention · NA · unknown
- NCT03929081 — Alternative Treatment to Reduce Chronicity in OCD: Research Into Brain Response and Adequacy of Treatment · NA · completed
- NCT03157557 — Multidisciplinary Lifestyle-enhancing Treatment for People With Severe Mental Illness in Sheltered Housing Facilities · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04922749 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by GGZ Centraal
- Last refreshed: 16 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04922749.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing